We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

161 hedge funds and large institutions have $1.43B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

466% more call options, than puts

Call options by funds: $18.3M | Put options by funds: $3.23M

125% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 12

10% more funds holding

Funds holding: 147 → 161 (+14)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 52

8% less capital invested

Capital invested by funds: $1.56B → $1.43B (-$129M)

Holders
161
Holders Change
+14
Holders Change %
+9.52%
% of All Funds
2.82%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
52
Reduced
52
Closed
12
Calls
$18.3M
Puts
$3.23M
Net Calls
+$15.1M
Net Calls Change
+$10.9M

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$23.9M
2
EAM
Eventide Asset Management
Massachusetts
+$12.8M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$8.28M
4
SCM
Suvretta Capital Management
New York
+$6.69M
5
AC
Armistice Capital
New York
+$6.57M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$35.6M
2
DM
Deerfield Management
New York
-$16.9M
3
CCM
Consonance Capital Management
New York
-$14.2M
4
TCM
Tekla Capital Management
Massachusetts
-$11.3M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$8.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
101
Victory Capital Management
Texas
$530K +$4.88K +153 +1%
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$528K +$213K +6,686 +75%
MIM
103
MetLife Investment Management
New Jersey
$514K – – –
TD Asset Management
104
TD Asset Management
Ontario, Canada
$500K – – –
E
105
Ergoteles
New York
$468K +$439K +13,768 New
Squarepoint
106
Squarepoint
New York
$455K -$107K -3,348 -20%
VEA
107
Virtus ETF Advisers
New York
$431K -$37K -1,160 -8%
SLG
108
Stanley-Laman Group
Pennsylvania
$420K +$394K +12,349 New
AG
109
Algert Global
California
$381K +$358K +11,203 New
ASRS
110
Arizona State Retirement System
Arizona
$376K +$2.78K +87 +0.8%
MLICM
111
Metropolitan Life Insurance Company (MetLife)
New York
$370K – – –
WMSA
112
Weiss Multi-Strategy Advisers
New York
$364K +$7.44K +233 +2%
WG
113
Winton Group
United Kingdom
$337K +$316K +9,913 New
SG Americas Securities
114
SG Americas Securities
New York
$291K -$38.5K -1,207 -12%
Handelsbanken Fonder
115
Handelsbanken Fonder
Sweden
$289K – – –
JG
116
Jefferies Group
New York
$282K -$1.23M -38,660 -82%
BFM
117
Boothbay Fund Management
New York
$267K +$26.4K +826 +12%
CIM
118
CIM Investment Management
Pennsylvania
$256K – – –
AB
119
Amalgamated Bank
New York
$230K -$12.8K -401 -6%
M&T Bank
120
M&T Bank
New York
$230K -$64 -2 -0%
Teacher Retirement System of Texas
121
Teacher Retirement System of Texas
Texas
$221K +$207K +6,496 New
SEI Investments
122
SEI Investments
Pennsylvania
$214K -$15.9K -498 -7%
SM
123
SG3 Management
Puerto Rico
$204K +$191K +6,000 New
MAM
124
Martingale Asset Management
Massachusetts
$201K +$96 +3 +0.1%
SO
125
STRS Ohio
Ohio
$197K +$182K +5,700 +5,700%
3 4
5
6 7

DCPH Hedge Fund Activity: Q3 2021 in Review

161 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2021, worth a combined $1.43B — down 8.3% from $1.56B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new DCPH positions and 12 closed out — a net gain of 15 holders — while 52 added to existing stakes and 52 trimmed.

The largest buyer was Logos Global Management, adding an estimated $23.9M. The largest seller was OrbiMed, cutting an estimated $35.6M.

  • 161 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2021, up from 147 in Q2 2021.
  • Funds reported $1.43B of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2021, down 8.3% quarter-over-quarter.
  • 27 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2021 and 12 closed out, a net change of +15 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q3 2021 was Logos Global Management, an estimated $23.9M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2021 was OrbiMed, an estimated $35.6M sold.

Based on aggregated 13F filings for Q3 2021.